News

f2-840825-1408521076351.png

While at the 2014 Partnerships in Clinical Trials Conference, Adrian Otte, VP of Global Development Operations at Amgen, spoke about how Amgen's Risk-Based Monitoring and FSP models impacted business outcomes.

A management report from Tufts CSDD, based on an executive roundtable, found that drug companies and their development partners are incorporating business planning earlier in clinical development

BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient.